Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) said data to be presented demonstrates that Tarvacin has significant anti-viral activity in the treatment ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE